Maxlinear (MXL) Research & Development (2010 - 2026)

Maxlinear has disclosed Research & Development across 17 years of filings, most recently posting $53.2 million for Q1 2026.

• In Q1 2026, Research & Development fell 4.14% year-over-year to $53.2 million; the TTM figure through Mar 2026 stood at $206.3 million (down 4.44% YoY), while the FY2025 annual figure was $208.6 million, down 7.37% from the prior year.
• Research & Development rose to $53.2 million in Q1 2026, from $51.7 million in the prior quarter.
• Over the last five years, Research & Development for MXL reached as high as $80.4 million in Q2 2022 and fell as low as $47.2 million in Q2 2025.
• The 5-year median for Research & Development is $64.8 million (2024), against an average of $61.9 million.
• Annual changes were most pronounced in 2022 — Research & Development grew 13.18% — and 2024, when it declined 21.41%.
• A 5-year view of Research & Development shows it stood at $73.7 million in 2022, then slipped by 11.49% to $65.2 million in 2023, then decreased by 21.41% to $51.3 million in 2024, then advanced by 0.81% to $51.7 million in 2025, then rose by 2.85% to $53.2 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $53.2 million, $51.7 million, and $54.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.